← All claims

Longevity & Aging · Metabolic & Cardiometabolic

dietary and anti-aging supplements does not improve hard health outcomes

In plain terms: Without a diagnosed deficiency, do supplements fail to improve hard health outcomes?

Leans support Longevity & Aging 🔬 Includes disconfirming

Part of: • Aging

RefutedContestedStrong support
consensus score 0.54

Broadly supported for hard endpoints (mortality, CVD, cancer) where multivitamins and popular longevity supplements show null RCT results — but not absolute: at least one large RCT (COSMOS) found a modest multivitamin benefit on cognition.

📅 Last reviewed: 2026-07-14 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

8 support 2 contradict 1 tested null 3 mixed · 14 sources, 8 independent groups

What the evidence shows

For hard endpoints the evidence supports this: SELECT found no cancer prevention from selenium or vitamin E, a Cochrane analysis of twelve trials in 19,715 people found no selenium benefit, and vitamin D did not prevent type 2 diabetes in VITAL. Not absolute — COSMOS-Mind found a modest multivitamin benefit on cognition, so it holds for mortality and disease, not everything.

The evidence (15)

SourceGradeStanceQualityFinding
Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL, Baker LH, Coltman CA
2009 · JAMA
RCT supports high SELECT: selenium and/or vitamin E did not prevent prostate or other cancers in generally healthy men, supporting no-benefit.
Baker LD, Manson JE, Rapp SR, Sesso HD, Gaussoin SA, Shumaker SA, Espeland MA
2023 · Alzheimers Dement
RCT mixed moderate COSMOS-Mind: multivitamin showed a modest cognitive benefit in older adults while cocoa extract did not, a partial exception on a soft outcome.
Rees K, Hartley L, Day C, Flowers N, Clarke A, Stranges S
2013 · The Cochrane database of systematic reviews
meta-analysis supports high Cochrane meta-analysis of 12 RCTs (19,715 participants) found selenium supplementation had no significant effect on all-cause mortality (RR 0.97), CVD mortality (RR 0.97), or CVD events, concluding trial evidence does not support selenium f
Tobias DK, Pradhan AD, Duran EK, Li C, Song Y, Buring JE, Cook NR, Mora S, Manson JE
2025 · Nat Commun
RCT supports high VITAL-T2D: vitamin D supplementation did not reduce incident type 2 diabetes in a general older US population.
Yeung LK, Alschuler DM, Wall M, Luttmann-Gibson H, Copeland T, Hale C, Sloan RP, Sesso HD, Manson JE, Brickman AM
2023 · Am J Clin Nutr
RCT contradicts moderate COSMOS multivitamin RCT: modest improvement in memory/cognition in older adults without diagnosed deficiency — a genuine positive exception that narrows the absolute claim.
Alexander DD, Weed DL, Chang ET, Miller PE, Mohamed MA, Elkayam L
2013 · J Am Coll Nutr
meta-analysis supports moderate 12 cohorts plus 3 RCTs: multivitamin use not associated with reduced all-cause/CVD/cancer mortality in healthy adults — null for the outcomes that matter.
Park SJ, Manson JE, Kim E, Glynn RJ, Rist PM, Allison MA, Sesso HD
2026 · Thromb Haemost
RCT supports moderate COSMOS ancillary: neither cocoa extract nor multivitamin significantly reduced venous thromboembolism in older adults.
Holanda MT, Mediano MFF, Hasslocher-Moreno AM, Gonzaga BMS, Carvalho ACC, Ferreira RR, Garzoni LR, Pereira-Silva FS, Pimentel LO, Mendes MO, Azevedo MJ, Britto C, Moreira OC, Fernandes AG, Santos CM, Constermani J, Paravidino VB, Maciel ER, Carneiro FM, Xavier SS, Sperandio da Silva GM, Santos PF, Veloso HH, Brasil PEAA, de Sousa AS, Bonecini-de-Almeida MG, da Silva PS, Sangenis LHC, Saraiva RM, Araujo-Jorge TC
2021 · EClinicalMedicine
RCT tested-null low RCT of selenium 100mcg/day vs placebo for 1 year in 66 Chagas cardiomyopathy patients found no significant improvement in primary outcome (LVEF) overall. A small subgroup (B2 stage, n=12) showed a signal, but this is not a hard-outcome bene
Ogata S, Manson JE, Kang JH, Buring JE, Lee IM, Nishimura K, Sakata Y, Danik JS, D'Agostino D, Mora S, Albert CM, Cook NR
2023 · Nutrients
RCT mixed moderate Reanalysis of VITAL using win-ratio composite outcomes found marine n-3 supplementation did not meaningfully reduce cardiovascular events in healthy older adults.
Li J, Sesso HD, Kim E, Manson JE, Friedenberg G, Clar A, Copeland T, Shadyab AH, Wactawski-Wende J, Tinker L, Liu S
2023 · Diabetes Care
RCT supports high COSMOS: cocoa extract supplementation did not reduce incident type 2 diabetes in older adults, supporting no hard-outcome benefit.
Setayesh A, Arzhang P, Baniasadi MM, Lahouti M, Azadbakht L
2026 · Int J Obes
meta-analysis mixed moderate Resveratrol RCT meta-analysis: inconsistent/inconclusive effects on anthropometrics and adipokines — no reliable outcome benefit, consistent with claim.
Gaziano JM, Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, Schvartz M, Manson JE, Glynn RJ, Buring JE
2012 · JAMA
RCT contradicts high PHS II: daily multivitamin modestly but significantly reduced total cancer incidence in male physicians, a hard-outcome benefit that partly contradicts the no-benefit claim.
O'Connor EA, Evans CV, Ivlev I, Rushkin MC, Thomas RG, Martin A, Lin JS
2022 · JAMA
meta-analysis supports high USPSTF evidence review: insufficient/no benefit of vitamin-mineral supplements for preventing CVD or cancer in generally healthy, non-deficient adults; possible harm (beta-carotene) — strongly supports the claim for hard outcomes.
Vinceti M, Filippini T, Del Giovane C, Dennert G, Zwahlen M, Brinkman M, Zeegers MP, Horneber M, D'Amico R, Crespi CM
2018 · The Cochrane database of systematic reviews
meta-analysis supports high Cochrane meta-analysis of 10 RCTs (27,232 participants) found selenium supplementation did not reduce cancer incidence (RR 1.01) or mortality (RR 1.02) versus placebo; some RCTs showed increased risk of high-grade prostate cancer, type 2 di
Neves PM, Almeida S, Domingues V
2026 · Cureus
observational supports low Narrative review, not evidence: 'Narrative review of guidelines, randomized trials, and meta-analyses indexed in major databases (2000-August 2025).' 'This is not a systematic review.' Concludes 'In generally nourished adults, multivitamins do not reduce cardiovascular events or mortality'. Review — zero weight.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.